Kimiyo M. Raymond

Dr. Kimiyo M. Raymond is a Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic College of Medicine and Science in Rochester, Minnesota. As a Medical Geneticist specializing in biochemical genetics, she has established herself as a leading researcher in congenital disorders of glycosylation (CDG) and metabolic disorders. Her work bridges clinical practice with advanced laboratory diagnostics.

Dr. Raymond's research focuses primarily on congenital disorders of glycosylation, lysosomal storage disorders, and newborn screening methodologies. She has made significant contributions to understanding the biochemical mechanisms, diagnostic approaches, and therapeutic interventions for various CDG subtypes including PMM2-CDG, PGM1-CDG, and ALG-related disorders. Her work has been instrumental in developing biomarkers for disease severity assessment and monitoring treatment efficacy. She has also contributed to international consensus guidelines for the diagnosis and management of several CDG subtypes.

Her recent publications demonstrate an increasing focus on developing novel diagnostic methods, identifying biomarkers for disease severity, and establishing treatment monitoring protocols for various metabolic disorders. She frequently collaborates with international research teams through consortia such as the University of Washington Center for Mendelian Genomics.

• 1997 Award from the Brazilian Cardiology Society
• 1995 Dr. Lefevre Award for Best Scientific Research from the Brazilian Society of Neurology & Pediatric Neurology
• 1991 Scholarship Award from the Brazilian National Council for Science and Technological Development

Dr. Raymond maintains active professional memberships including the Society for Inherited Metabolic Disease, Society for the Study of Inborn Errors of Metabolism, and Brazilian Society for Clinical Genetics. Her work continues to advance the field of biochemical genetics through both laboratory research and clinical applications, with a particular emphasis on improving diagnostic accuracy and developing targeted therapeutic approaches for rare metabolic disorders.